Melanotan 1 and Melanotan 2 are two of the most discussed peptides in the research community. Both are synthetic analogues of alpha-melanocyte-stimulating hormone (α-MSH), and both influence melanin — the pigment responsible for skin colour — but they are not the same compound. They differ in structure, in the receptors they target, and in the breadth of effects observed in research settings. This guide breaks down the key differences between Melanotan 1 (MT-1) and Melanotan 2 (MT-2).
What Is Melanotan 1 (MT-1)?
Melanotan 1 (MT-1) is a linear peptide analogue of α-MSH. It is highly selective for the melanocortin 1 receptor (MC1R), the receptor most closely associated with melanin production (melanogenesis). Because of this selectivity, research on MT-1 has focused largely on pigmentation and photoprotection. Its clinically developed counterpart, afamelanotide, is an approved MC1R agonist used to manage erythropoietic protoporphyria (EPP), a rare light-sensitivity disorder — making MT-1 one of the better-characterised melanocortin peptides in the scientific literature.
What Is Melanotan 2 (MT-2)?
Melanotan 2 (MT-2) is a cyclic peptide and a non-selective melanocortin agonist. Rather than targeting MC1R alone, it activates a wider range of melanocortin receptors — MC1R, MC3R, MC4R and MC5R — which are linked not only to pigmentation but also to appetite, metabolism and sexual-function pathways. This broader receptor activity is why MT-2 is associated with faster, deeper pigmentation in studies, but also a wider range of observed side effects.
Melanotan 1 vs Melanotan 2: Side-by-Side Comparison
| Feature | Melanotan 1 (MT-1) | Melanotan 2 (MT-2) |
|---|---|---|
| Peptide structure | Linear (α-MSH analogue) | Cyclic |
| Receptor activity | Highly selective for MC1R | Non-selective (MC1R, MC3R, MC4R, MC5R) |
| Primary research effect | Melanin / pigmentation | Pigmentation + appetite & other pathways |
| Pigmentation in studies | Gradual, more uniform | Faster, deeper |
| Side-effect profile | Narrower (more selective) | Broader |
| Clinical counterpart | Afamelanotide (approved for EPP) | None approved |
| Best suited to | MC1R / photoprotection research | Multi-receptor melanocortin research |
How They Work: Receptor Selectivity Explained
The core difference comes down to receptor selectivity. When skin is exposed to UV radiation, keratinocytes release α-MSH, which binds to MC1R on melanocytes. This raises cyclic AMP (cAMP) and activates melanogenic enzymes such as tyrosinase, increasing melanin synthesis. MT-1 mimics this pathway in a targeted way — binding MC1R with high affinity and largely leaving the other melanocortin receptors alone. MT-2 is less discriminating: by also activating MC3R, MC4R and MC5R, it produces effects beyond pigmentation, which accounts for both its potency and its broader side-effect profile.
Pigmentation Differences in Research
In research observations, MT-2 tends to produce a faster and more pronounced increase in pigmentation because it is more potent across multiple receptors. MT-1, being MC1R-selective, is associated with a more gradual and uniform response. Researchers often frame the choice as potency (MT-2) versus selectivity (MT-1).
Side Effect Profiles
Because MT-2 activates MC4R and other central receptors, the research literature reports a broader range of effects — including nausea, facial flushing, appetite changes and effects on sexual function. MT-1's MC1R selectivity means its observed effects are generally narrower and more confined to pigmentation pathways. This is a key reason MT-1 is described as the "more selective" of the two.
Which Has More Research Behind It?
MT-1 has the advantage in clinical characterisation. Its analogue afamelanotide has completed formal clinical development and is approved in the EU and US for EPP. MT-2 has been studied for other melanocortin-mediated effects but has no approved therapeutic counterpart. For researchers prioritising a well-documented MC1R agonist, MT-1 is the more established choice.
Is Melanotan Legal in the UK?
In the UK, Melanotan is not licensed as a medicine for human use, and the MHRA has stated that selling or advertising Melanotan for human consumption is unlawful. Compounds such as MT-1 and MT-2 are therefore supplied strictly as research chemicals — for laboratory and research use only, and not for human consumption. Always buy from suppliers that provide clear labelling and certificates of analysis (COAs).
Melanotan 1 vs Melanotan 2: Which Should Researchers Choose?
There is no single "better" peptide — it depends on the research objective:
- Choose MT-1 for MC1R-selective pigmentation or photoprotection research, or when a well-characterised, clinically referenced peptide is preferred.
- Consider MT-2 for research into broader melanocortin-receptor activity across pigmentation, appetite and related pathways.
Frequently Asked Questions
What is the main difference between Melanotan 1 and Melanotan 2?
Melanotan 1 is a linear peptide that selectively targets the MC1R receptor for pigmentation, while Melanotan 2 is a cyclic peptide that activates multiple melanocortin receptors (MC1R–MC5R), giving it broader effects.
Is Melanotan 1 stronger than Melanotan 2?
In terms of raw potency, MT-2 is generally more potent because it acts on more receptors. MT-1 is more selective, which is why it is associated with a narrower, more targeted effect profile.
Does Melanotan 1 have fewer side effects than Melanotan 2?
In the research literature MT-1's MC1R selectivity is linked to a narrower range of observed effects, whereas MT-2's multi-receptor activity is linked to a broader side-effect profile.
Is Melanotan 1 the same as afamelanotide?
Afamelanotide is the clinically developed analogue of Melanotan 1 and is an approved MC1R agonist used for erythropoietic protoporphyria (EPP).
Is Melanotan legal in the UK?
Melanotan is not licensed for human use in the UK, and selling it for human consumption is unlawful. It is supplied only as a research chemical, for laboratory use and not for human consumption.
Disclaimer
The compounds discussed in this article are sold and intended for laboratory and research use only. They are not for human consumption, are not medicines, and nothing here constitutes medical advice. Always follow the regulations that apply in your country.
⚠ All products are for research and laboratory purposes only. Not for human consumption.